Praxis für Urologie, Rigaer Strasse 9, 17993, Greifswald, Deutschland.

This email address is being protected from spam bots, you need Javascript enabled to view it

The aim of this non-interventional study was to evaluate the efficacy and tolerability of propiverine ER under real life conditions.

The treatment of 5,565 patients with urge urinary incontinence, urgency or mixed urinary incontinence was documented over a 12-week period. Incontinence episodes, voiding frequency and voided volume were recorded at 3 visits (admission, after 4 and 12 weeks). Additionally the tolerability was evaluated at visits 2 and 3.

The average incontinence episodes/24 h decreased during therapy from 4.23 to 2.89. The frequency of micturitions/24 h decreased by 5.50. The voided volume improved by 69 ml. Approximately 92 % of investigators and patients assessed the efficacy similarly with "very good" and "good". Dry mouth was the most frequent adverse drug reaction and decreased from 16.5 % after 4 weeks to 13.6 % after 12 weeks of treatment.

The efficacy and tolerability of propiverine ER were confirmed under real life conditions.

Article in German

Written by:
Kessler-Zumpe PL, Murgas S, Neumann G, Richter AE.   Are you the author?

Reference:
Urologe A. 2009 Sep 2. Epub ahead of print.
doi:10.1007/s00120-009-2086-1

PubMed Abstract
PMID:19727644

UroToday.com Overactive Bladder (OAB) Section

Please log-in or register in order to submit comments.

Powered by AkoComment!